Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
blarcamesine
product2 mentionslast seen Oct 20, 2026
Investigational drug for treatment of Fragile X syndrome, Alzheimer's disease and Rett syndrome.
Relationships 9
- blarcamesineapplies toFragile X syndrome treatment99% confidence2 sources
- Anavex Life Sciences Corp.developsblarcamesine99% confidence2 sources
- blarcamesineapplies toRett syndrome treatment99% confidence2 sources
- U.S. Food and Drug Administrationapprovesblarcamesine93% confidence1 source
- Anavex Life Sciences Corp.approvesblarcamesine92% confidence1 source
- blarcamesineconforms toOrphan Drug designation90% confidence1 source
- blarcamesineapplies toearly Alzheimer's disease treatment90% confidence1 source
- blarcamesineapplies toAlzheimer's disease treatment88% confidence1 source
- blarcamesinedepends onsigma-1 receptor agonist85% confidence1 source
Relationship
Anavex Life Sciences Corp.approvesblarcamesine
92% confidence1 supporting mentionsfrom Oct 15, 2026
Either name opens that entity’s relationships.
Sources 1